Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Researchers unveil GPX8 as a potential target for TNBC

Dec. 13, 2021

KMT2D is a therapeutic target in breast cancer

Dec. 13, 2021

TYK Medicines patents RET inhibitors

Dec. 13, 2021

Totus receives financing to advance TOS-358 drug program for cancer

Dec. 10, 2021

Beijing Findcure Biosciences divulges tyrosine-protein kinase receptor UFO inhibitors

Dec. 10, 2021

New BRD4 BD2 inhibitors discovered at Betta Pharmaceuticals

Dec. 10, 2021

Discovery of novel o-aminobenzamide derivative with promising activity in models of gastric cancer

Dec. 9, 2021

Dual BRD4 and ULK3 inhibition as novel therapeutic strategy for TNBC

Dec. 9, 2021

EZH2 methylation of p38 linked to breast cancer progression

Dec. 9, 2021

New ENPP1 inhibitors discovered at Vir Biotechnology

Dec. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.